Similar articles for PMID: 36990222

Year	Number of Results
1995	1
1996	1
1999	2
2000	3
2003	1
2007	2
2008	1
2010	2
2011	4
2013	3
2014	2
2015	3
2016	5
2017	8
2018	6
2019	9
2020	11
2021	20
2022	15
2023	19
2024	3

1

Effect of Autograft CD34⁺ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors.

Knight TE, Ahn KW, Hebert KM, Atshan R, Wall DA, Chiengthong K, Rotz SJ, Fraint E, Rangarajan HG, Auletta JJ, Sharma A, Kitko CL, Hashem H, Williams KM, Wirk B, Dvorak CC, Myers KC, Pulsipher MA, Warwick AB, Lalefar NR, Schultz KR, Qayed M, Broglie L, Eapen M, Yanik GA. Knight TE, et al. Transplant Cell Ther. 2023 Jun;29(6):380.e1-380.e9. doi: 10.1016/j.jtct.2023.03.024. Epub 2023 Mar 27. Transplant Cell Ther. 2023. PMID: 36990222 Free PMC article.

2

High CD34-positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft-versus-host disease or mortality.

Avigan ZM, Dias AL, Dodge LE, Arnason JE, Joyce RM, Liegel J, Rosenblatt J, Weinstock MJ, Avigan DE, Haspel RL. Avigan ZM, et al. Transfusion. 2024 Jun;64(6):1068-1075. doi: 10.1111/trf.17864. Epub 2024 May 1. Transfusion. 2024. PMID: 38693089

3

Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.

Glushkova S, Shelikhova L, Voronin K, Pershin D, Vedmedskaya V, Muzalevskii Y, Kazachenok A, Kurnikova E, Radygina S, Ilushina M, Khismatullina R, Maschan A, Maschan M. Glushkova S, et al. Transplant Cell Ther. 2024 Apr;30(4):435.e1-435.e12. doi: 10.1016/j.jtct.2024.01.070. Epub 2024 Jan 24. Transplant Cell Ther. 2024. PMID: 38278183

4

Clinical Outcomes of Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma Patients: A 5-year Experience from a Single Centre in North India.

Sood N, Tiwari AK, Pabbi S, Dikshit R, Singh P, Ramaswami A, Gautam D, Singh MK. Sood N, et al. South Asian J Cancer. 2022 Aug 16;12(2):185-189. doi: 10.1055/s-0042-1748184. eCollection 2023 Apr. South Asian J Cancer. 2022. PMID: 37969670 Free PMC article.

5

Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia.

Llaurador G, Shaver K, Wu M, Wang T, Gillispie A, Doherty E, Craddock J, Read J, Yassine K, Morales E, George A, Steffin D, Krance R, Martinez C, Heslop H, Salem B. Llaurador G, et al. Transplant Cell Ther. 2024 Feb;30(2):217-227. doi: 10.1016/j.jtct.2023.10.024. Epub 2023 Nov 4. Transplant Cell Ther. 2024. PMID: 37931800

6

Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysis.

Yadav N, Mirgh SP, Aggarwal M, Agrawal N, Mehta P, Khushoo V, Kapoor J, Bhatia N, Agrawal P, Ahmed R, Bhurani D. Yadav N, et al. Indian J Cancer. 2023 Jul-Sep;60(3):316-324. doi: 10.4103/ijc.IJC_272_21. Indian J Cancer. 2023. PMID: 37787191 Free article.

7

Impact of thiotepa dose-intensity in primary diffuse large B-cell lymphoma of the central nervous system undergoing autologous hematopoietic cell transplant with thiotepa/carmustine conditioning.

Arshad S, Fang X, Ahn KW, Kaur M, Scordo M, Sauter CS, Furqan F, Awan FT, Hamadani M. Arshad S, et al. Bone Marrow Transplant. 2023 Nov;58(11):1203-1208. doi: 10.1038/s41409-023-02071-8. Epub 2023 Aug 10. Bone Marrow Transplant. 2023. PMID: 37563283

8

Selection of hematopoietic stem cell transplantation for T-cell lymphoblastic lymphoma.

Li Z, Zhang B, Fan X, Gui R, Yu F, Wang J, Zhang Y, Zhou K, Liu Y, Li Y, Ding J, Song Y, Zhou J. Li Z, et al. Front Oncol. 2023 Jul 20;13:1193237. doi: 10.3389/fonc.2023.1193237. eCollection 2023. Front Oncol. 2023. PMID: 37546390 Free PMC article.

9

Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patients.

Jeon Y, Kim TY, Min GJ, Park SS, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Lee JW, Cho SG. Jeon Y, et al. Cytotherapy. 2023 Dec;25(12):1307-1316. doi: 10.1016/j.jcyt.2023.07.005. Epub 2023 Aug 4. Cytotherapy. 2023. PMID: 37542512 Free article.

10

Analysis benefits of a second Allo-HSCT after CAR-T cell therapy in patients with relapsed/refractory B-cell acute lymphoblastic leukemia who relapsed after transplant.

Cao XY, Zhang JP, Zhao YL, Xiong M, Zhou JR, Lu Y, Sun RJ, Wei ZJ, Liu DY, Zhang X, Yang JF, Lu P. Cao XY, et al. Front Immunol. 2023 Jul 4;14:1191382. doi: 10.3389/fimmu.2023.1191382. eCollection 2023. Front Immunol. 2023. PMID: 37469510 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year